Results of the U.S. Multicenter Pivotal Study of the HELEX Septal Occluder for Percutaneous Closure of Secundum Atrial Septal Defects
Thomas K. Jones, MD, FACC*,*,
Larry A. Latson, MD, FACC ,
Evan Zahn, MD, FACC ,
Craig E. Fleishman, MD, FACC ,
Joth Jacobson, MS¶,
Robert Vincent, MD, FACC||,
Kirk Kanter, MD|| for the Multicenter Pivotal Study of the HELEX Septal Occluder Investigators#
* Children's Heart Center, Children's Hospital and Regional Medical Center, Seattle, Washington
Department of Pediatric Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio
The Congenital Heart Institute, Miami Children's Hospital, Miami, Florida
The Congenital Heart Institute, Arnold Palmer Children's Hospital, Orlando, Florida
¶ Gore Medical Products, W. L. Gore & Associates, Inc., Flagstaff, Arizona
|| Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia
The Multicenter Pivotal Study of the Helex Septal Occluder Investigators are listed in the .

View larger version (82K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 The HELEX Septal Occluder Is Shown Attached to the Integral Delivery System
By partially extending the mandrel within the control catheter, the left and right atrial disks of the occluder can be shown in this image.
|
|
|